» Articles » PMID: 1497622

Different Culture Methods Lead to Differences in Glycosylation of a Murine IgG Monoclonal Antibody

Overview
Journal Biochem J
Specialty Biochemistry
Date 1992 Aug 1
PMID 1497622
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

A monoclonal IgG-1 was produced by culture of a murine hybridoma (3.8.6) by three different methods, namely culture in ascites, in serum-free media and in serum-supplemented media. IgG-1 was purified to homogeneity (as judged by SDS/PAGE under reducing conditions) from each medium by ion-exchange chromatography and h.p.l.c. Protein A chromatography. Oligosaccharides were released from each IgG-1 preparation by hydrazinolysis and radiolabelled by reduction with alkaline sodium borotritide, and 'profile' analysis of the radiolabelled oligosaccharide alditols was performed by a combination of paper electrophoresis and gel-filtration chromatography. This analysis indicated clear and reproducible differences in the glycosylation patterns of the three IgG-1 preparations. Sequential exoglycosidase analysis of individual oligosaccharides derived from each IgG-1 preparation was used to define these differences. Ascites-derived material differed from serum-free-culture-derived material only with respect to the content of sialic acid. IgG-1 derived from culture in serum-containing media had an intermediate sialic acid content and a lower incidence of outer-arm galactosylation than the other two preparations. These differences in glycosylation could not be induced in any IgG-1 preparation by incubating purified IgG-1 with ascites or culture medium. It is concluded that the glycosylation pattern of a secreted monoclonal IgG is dependent on the culture method employed to obtain it.

Citing Articles

Modulating antibody effector functions by Fc glycoengineering.

Garcia-Alija M, Van Moer B, Sastre D, Azzam T, Du J, Trastoy B Biotechnol Adv. 2023; 67:108201.

PMID: 37336296 PMC: 11027751. DOI: 10.1016/j.biotechadv.2023.108201.


Design of a stabilized non-glycosylated Pfs48/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccine.

Dickey T, Gupta R, McAleese H, Ouahes T, Orr-Gonzalez S, Ma R NPJ Vaccines. 2023; 8(1):20.

PMID: 36808125 PMC: 9938515. DOI: 10.1038/s41541-023-00619-9.


Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies.

van der Horst H, Nijhof I, Mutis T, Chamuleau M Cancers (Basel). 2020; 12(10).

PMID: 33086644 PMC: 7603375. DOI: 10.3390/cancers12103041.


Synthetic Glycobiology: Parts, Systems, and Applications.

Kightlinger W, Warfel K, DeLisa M, Jewett M ACS Synth Biol. 2020; 9(7):1534-1562.

PMID: 32526139 PMC: 7372563. DOI: 10.1021/acssynbio.0c00210.


EGCG improves recombinant protein productivity in Chinese hamster ovary cell cultures via cell proliferation control.

Yamano N, Omasa T Cytotechnology. 2018; 70(6):1697-1706.

PMID: 30069612 PMC: 6269352. DOI: 10.1007/s10616-018-0243-3.


References
1.
HYMES A, MULLINAX G, MULLINAX F . Immunoglobulin carbohydrate requirement for formation of an IgG-IgG complex. J Biol Chem. 1979; 254(9):3148-51. View

2.
Sutton B, Phillips D . The three-dimensional structure of the carbohydrate within the Fc fragment of immunoglobulin G. Biochem Soc Trans. 1983; 11 Pt 2:130-2. View

3.
Parekh R, Tse A, Dwek R, Williams A, Rademacher T . Tissue-specific N-glycosylation, site-specific oligosaccharide patterns and lentil lectin recognition of rat Thy-1. EMBO J. 1987; 6(5):1233-44. PMC: 553924. DOI: 10.1002/j.1460-2075.1987.tb02359.x. View

4.
Sheares B, Robbins P . Glycosylation of ovalbumin in a heterologous cell: analysis of oligosaccharide chains of the cloned glycoprotein in mouse L cells. Proc Natl Acad Sci U S A. 1986; 83(7):1993-7. PMC: 323216. DOI: 10.1073/pnas.83.7.1993. View

5.
Malaise M, Franchimont P, Gomez F, Bouillenne C, Mahieu P . The spontaneous ability of normal human IgG to inhibit the Fc receptors of normal human monocytes is related to their binding capacity to lectins. Clin Immunol Immunopathol. 1987; 45(1):1-16. DOI: 10.1016/0090-1229(87)90106-1. View